| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 01/23/2003 | US20030017550 Nucleotide sequences coding polypeptide for use in the treatment of viral, neoplastic, multiple sclerosis and immunological disorders |
| 01/23/2003 | US20030017547 Nucleotide sequences coding polypeptide for use in the treatment of cancer |
| 01/23/2003 | US20030017538 Genetically engineered protein for use as diagnostic tool in gentic analysis |
| 01/23/2003 | US20030017537 Amplified genetic expression of genetically engineered hemoglobin; obtain cell, transform with vector coding genetically engineered hemoglobin, express vector, recover hemoglobin |
| 01/23/2003 | US20030017533 Slo2 and Slo4, novel potassium channel proteins from human brain |
| 01/23/2003 | US20030017532 ndp |
| 01/23/2003 | US20030017531 Preparation of a recombinant protein in a prokaryotic host cell |
| 01/23/2003 | US20030017527 Human vanilloid receptor-like proteins |
| 01/23/2003 | US20030017512 Angiostatin receptor |
| 01/23/2003 | US20030017495 Enterococcus faecalis polynucleotides and polypeptides |
| 01/23/2003 | US20030017494 Genes encoding mycobacterial proteins associated with cell binding and cell entry and uses thereof |
| 01/23/2003 | US20030017480 Novel genes encoding protein kinase/protein phosphatase |
| 01/23/2003 | US20030017478 Collection of prokaryotic DNA for two hybrid systems Helicobacter pylori protein-protein interactions and application thereof |
| 01/23/2003 | US20030017452 Nucleotide sequences coding polypeptide for use in the prevention and treatment of infections and cancer |
| 01/23/2003 | US20030017161 Polypeptides that are capable of modulating apoptosis; also Apo-2 chimeras, nucleic acid encoding Apo-2, and antibodies to Apo-2 |
| 01/23/2003 | US20030017157 Endothelial cell expression patterns |
| 01/23/2003 | US20030017138 Chimeric adenoviruses |
| 01/23/2003 | US20030017134 Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer |
| 01/23/2003 | US20030015467 Microbiological water filter |
| 01/23/2003 | CA2707767A1 Biologically active peptides |
| 01/23/2003 | CA2455615A1 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 01/23/2003 | CA2453672A1 Root nodule bacteria having enhanced nitrogen-fixation ability |
| 01/23/2003 | CA2453566A1 Method and composition for inhibiting heparanase activity |
| 01/23/2003 | CA2453534A1 Method for obtaining a titrated preparation of algae and resulting titrated preparations |
| 01/23/2003 | CA2453496A1 Survivin interacting protein tpr1 |
| 01/23/2003 | CA2453494A1 Histidine phosphatase interacting protein with 180kd |
| 01/23/2003 | CA2453435A1 Human mini-antibody cytotoxic for tumor cells which express the erbb2 receptor |
| 01/23/2003 | CA2453183A1 In vivo production of small interfering rnas that mediate gene silencing |
| 01/23/2003 | CA2452876A1 Imaging infection using fluorescent protein as a marker |
| 01/23/2003 | CA2452867A1 Allelic variants of gpr50 |
| 01/23/2003 | CA2452619A1 Disposable vessel |
| 01/23/2003 | CA2452517A1 Recombinant vsv for the treatment of tumor cells |
| 01/23/2003 | CA2452476A1 Mediating the effects of alcohol consumption by orally administering active dry yeast |
| 01/23/2003 | CA2452417A1 Compositions comprising the biologicially active peptide ysl |
| 01/23/2003 | CA2451217A1 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 01/23/2003 | CA2449411A1 Human cytokine receptor |
| 01/23/2003 | CA2448517A1 Process for the preparation of 2,4-dideoxyhexoses and 2,4,6-trideoxyhexoses |
| 01/22/2003 | EP1277837A2 Epididymis-specific DNA sequences and their use |
| 01/22/2003 | EP1277834A1 Glucuronofucan sulfate |
| 01/22/2003 | EP1277764A2 Allergenic proteins and peptides from dog dander and uses therefor |
| 01/22/2003 | EP1277763A1 Polypeptides having larvae growth inhibiting or insecticidal effect on scarabaeidae insects and polynucleotides encoding the same |
| 01/22/2003 | EP1277762A2 Low allergenic protein variants |
| 01/22/2003 | EP1277400A1 Compositions for the preservation of living biological materials and methods of their use |
| 01/22/2003 | EP1277019A1 Torsion generator |
| 01/22/2003 | EP1276902A2 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides |
| 01/22/2003 | EP1276893A1 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same |
| 01/22/2003 | EP1276892A2 A bacterial two-hybrid system for protein interaction screening |
| 01/22/2003 | EP1276891A1 A method for enhancing levels of polyunsaturated fatty acids in thraustochytrids |
| 01/22/2003 | EP1276887A2 Protection against environmental toxicity through manipulation of the processing of messenger rna precursors |
| 01/22/2003 | EP1276885A2 Trophic conversion of obligate phototrophic algae through metabolic engineering |
| 01/22/2003 | EP1276882A2 Method for genetically modifying a plant |
| 01/22/2003 | EP1276880A2 Polymorphisms in the human cyp2d6 gene promoter region and their use in diagnostic and therapeutic applications |
| 01/22/2003 | EP1276876A2 Expression-regulating sequences and expression products in the field of filamentous fungi: chrysosporium |
| 01/22/2003 | EP1276872A2 A thymus expressed human cytochrome p450 (p450tec) |
| 01/22/2003 | EP1276868A2 Identification of human gaba transporter |
| 01/22/2003 | EP1276866A2 Novel compounds |
| 01/22/2003 | EP1276863A1 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof |
| 01/22/2003 | EP1276857A1 Signal sequence trapping |
| 01/22/2003 | EP1276856A1 Albumin fusion proteins |
| 01/22/2003 | EP1276849A2 Albumin fusion proteins |
| 01/22/2003 | EP1276848A2 Apparatus and methods for testing effects of materials and surface coatings on the formation of biofilms |
| 01/22/2003 | EP1276764A1 Human polynucleotides, polypeptides, and antibodies |
| 01/22/2003 | EP1276762A1 Porphyromonas gingivalis recombinant proteins and truncations |
| 01/22/2003 | EP1276761A2 New bromodomain protein |
| 01/22/2003 | EP1276755A1 Novel compounds |
| 01/22/2003 | EP0853660B1 Method for preserving infectious recombinant viruses, aqueous viral suspension and use as medicine |
| 01/22/2003 | EP0627004B1 Improvements in or relating to malaria vaccine |
| 01/22/2003 | EP0540651B1 Endogenously sweetened transgenic plant products |
| 01/22/2003 | CN1392249A Pyrazinamide drug sensitive medium and its preparing method |
| 01/22/2003 | CN1392248A Broad spectrum bacillus thuringiensis and the method for preparing pesticide therewith |
| 01/22/2003 | CN1392247A Enzyme bathing sanitary material and its preparing method |
| 01/22/2003 | CN1392246A Acetic acid leakage type high-yield pyruvate bacterium and its breeding method and producing pyruvic acid by said bacterium via fermentation process |
| 01/22/2003 | CN1392245A Method for cultivating hair weeds cell |
| 01/22/2003 | CN1392244A Method for producing astaxanthin by cultivating haematococcus pulvialis |
| 01/22/2003 | CN1392243A Method for improving haematococcus pluvialis multiplication to produce pure strain in photo-biological reactor |
| 01/22/2003 | CN1392153A Process for prparing cytidine compound |
| 01/22/2003 | CN1392124A Microbial agriculture phosphate fertilizer prepared by using micro alternative biological electric field |
| 01/22/2003 | CN1392123A Microbial agriculture nitrogen fertilizer prepared by using micro alternative biological electric field |
| 01/22/2003 | CN1392122A Microbiological agriculture patash fertilizer prepared by using micro alternative biological electric field |
| 01/22/2003 | CN1392121A Microbiological agriculture fertilizer prepared by micro alternative biological electric field |
| 01/22/2003 | CN1099459C Defoamer for fermentation and process for fermentive production with use of the same |
| 01/22/2003 | CN1099393C Microbe preparation for decay straw or stalk of crops and its preparing process |
| 01/22/2003 | CN1099252C Aweto soy sauce and its preparing process |
| 01/22/2003 | CN1099228C Pingyu mushroom cultivating method with rice or wheat straw |
| 01/21/2003 | US6509455 Recombinant narbonolide polyketide synthase |
| 01/21/2003 | US6509447 G protein chimeras and methods of screening compounds |
| 01/21/2003 | US6509446 Recombinant genetic information (DNA or RNA), consisting a Chicken Anemia Virus (CAV)-specific nucleotide sequence, useful for diagonestics, vaccination or protein production |
| 01/21/2003 | US6509445 Effective metastasis inhibitory actions based on combined properties of two proteins; cancerous metastasis inhibitor with lower toxicity |
| 01/21/2003 | US6509373 Medium; a method for producing borrelidin utilizing the strain; and the novel uses of borrelidin for fungi |
| 01/21/2003 | US6509185 Provides for a 100-fold increase in the production of a protein from Bacillus subtilis |
| 01/21/2003 | US6509178 Process for preparing docosahexaenoic acid and docosapentaenoic acid with ulkenia |
| 01/21/2003 | US6509177 Cultivating on a medium comprising at least one organic nitrogen or carbon source, in submerged aerated conditions, a Pseudomonas bacterium strain capable of the biosynthesis of pseudomonic acid A |
| 01/21/2003 | US6509171 Aspartic proteinase deficient filamentous fungi |
| 01/21/2003 | US6509162 Methods for selectively modulating survivin apoptosis pathways |
| 01/21/2003 | US6509159 Methods related to Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins |
| 01/21/2003 | US6509156 Efficient homologous recombination mechanism between two DNA molecules occurs at usable frequencies in a bacterial host cell which is capable of expressing the products of the recE and recT genes or functionally related genes |
| 01/21/2003 | US6509155 Characterization, diagnosis, prevention, and treatment of cell signaling, immune, and cell proliferative disorders, particularly colon cancer |
| 01/21/2003 | US6509152 Immunosuppressant target proteins |
| 01/21/2003 | US6509151 DNA molecule encoding a Mycobacterium protein and conferring on Mycobacterium tuberculosis an ability to enter mammalian cells and to survive within macrophages |
| 01/21/2003 | US6509146 Scalable long-term shelf preservation of sensitive biological solutions and suspensions |